Frontiers in Public Health · Nov 17, 2026

Inequalities in cardiovascular risk and secondary prevention for cardiovascular disease between country-income levels: an individual-level pooled analysis of nationally representative survey in 50 low-, middle-and high-income countries

By Wenming Bian, Yetong Liu, Zhe Lv et al.

Introduction The increasing prevalence of cardiovascular disease (CVD) risk factors has contributed to a rising global burden of CVD. Understanding and managing this risk is crucial, particularly in diverse economic settings. Methods We conducted a cross-sectional analysis of adults using pooled individual-level data from nationally representative health surveys conducted between 2013 and 2023 across 50 low-, middle-, and high-income countries. Among subjects without CVD, individuals were classified as having low (<10%), medium (10-20%), or high (>20%) 10-year CVD risk based on WHO prediction charts. In participants with CVD, we particularly assessed the use of aspirin and/or statins for secondary prevention, stratified by country-income levels, age and sex. Results The pooled sample comprised 109,129 adults aged 40-69 years (mean age 52.7 years [95% CI: 52.5, 52.9]; 50.3% women [49.3, 51.3]). Among 97,491 individuals without CVD, 21.2% (20.3, 22.2) had a medium or high 10-year CVD risk. The proportion was 13.6% (12.2, 15.1) in low-income countries, 16.0% (15.2, 17.0) in lower-middle-income countries, 30.9% (30.0, 31.8) in upper-middle-income countries, and 33.2% (29.6, 37.0) in high-income countries. Among 11,638 individuals with CVD, aspirin or statins use was less common in countries with lower per capita income. The use of aspirin or statins for secondary prevention was 20.4% (14.4, 28.2) in low-income countries, 31.4% (28.3, 34.6) in lower-middle-income countries, 50.4% (47.4, 53.3) in upper-middle-income countries, and 87.6% (83.5, 90.9) in high-income countries. Conclusions Significant global disparities exist in CVD risk and the use of secondary prevention medications. Targeted strategies tailored to each country's socioeconomic and healthcare context are essential to reduce these gaps, especially in low-and lower-middle-income countries.

The paperJournal sitePopulations

AgingResearch.News